Effect of dietary supplementation with recombinant human lysozyme on growth performance, antioxidative characteristics, and intestinal health in broiler chickens
- PMID: 38745481
- PMCID: PMC11161903
- DOI: 10.1093/jas/skae121
Effect of dietary supplementation with recombinant human lysozyme on growth performance, antioxidative characteristics, and intestinal health in broiler chickens
Abstract
Lysozyme is often used as a feed additive to act as an antibacterial protein that boosts the immune system of livestock and poultry while protecting against pathogens. To investigate the effects of recombinant human lysozyme (rhLYZ) from Pichia pastoris and chlortetracycline on broiler chicken's production performance, antioxidant characteristics, and intestinal microbiota, a total of 200, 1-d-old male Arbor Acres broiler chickens (46.53 ± 0.42 g) were selected for a 42-d experiment. Dietary treatments included a basal diet of corn-soybean meal supplemented with either 0 mg/kg (CON), 50 mg/kg aureomycin (ANT), 20 mg/kg rhLYZ (LOW), 60 mg/kg rhLYZ (MEDIUM), or 180 mg/kg rhLYZ (HIGH). Compared with CON, MEDIUM diet increased (P < 0.05) average daily gain (67.40 g) of broilers from day 22 to 42. In the early (1.29) and overall phases (1.69), MEDIUM led to a reduction (P < 0.05) in the feed conversion ratio of broiler chickens. Furthermore, in comparison to the CON and ANT, MEDIUM exhibited reduced (P < 0.05) levels of INF-γ and tumor necrosis factor-α in the serum. In the cecum, the abundance of Monoglobus and Family_XIII_AD3011_group was lower (P < 0.05) in the MEDIUM treatment compared to CON. Overall, supplementation of 60 mg/kg of rhLYZ improved growth performance, nutrient utilization efficiency, and serum immune function, while also influencing the composition of intestinal microbiota. This suggests lysozyme's potential to replace antibiotic additives in feed.
Keywords: Pichia pastoris; broiler; human lysozyme; intestinal health; microorganisms.
Plain language summary
The aim of this study was to explore the effects of recombinant human lysozyme (rhLYZ) produced from Pichia pastoris and chlortetracycline on broiler chicken performance, antioxidant properties, and gut microbiota. A 42-d experiment was conducted, involving 200 1-d-old male Arbor Acres broiler chickens. We provided different diets: a standard diet (CON), a diet with 50 mg/kg aureomycin (ANT), a diet with 20 mg/kg rhLYZ (LOW), a diet with 60 mg/kg rhLYZ (MEDIUM), or a diet with 180 mg/kg rhLYZ (HIGH). The results showed that, compared to the control group, the MEDIUM group significantly increased the average daily gain of broilers to 67.40 g from day 22 to 42. Additionally, the MEDIUM group exhibited a reduced feed conversion ratio during both the early and overall growth stages of the chickens. Furthermore, serum levels of INF-γ and tumor necrosis factor-α were lower in the MEDIUM group compared to both the CON and ANT groups. In the cecum, the abundance of Monoglobus and Family_XIII_AD3011_group was also lower in the MEDIUM treatment compared to the CON group. Overall, supplementation with 60 mg/kg of rhLYZ improved growth performance, nutrient utilization efficiency, and serum immune function in broiler chickens while also influencing the composition of their intestinal microbiota. This suggests the potential of lysozyme as a replacement for antibiotic additives in feed.
© The Author(s) 2024. Published by Oxford University Press on behalf of the American Society of Animal Science. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Conflict of interest statement
The authors state that they do not have any known competing financial interests or personal ties that could to have influenced the work disclosed in this study.
Similar articles
-
Effects of natural capsicum extract on growth performance, nutrient utilization, antioxidant status, immune function, and meat quality in broilers.Poult Sci. 2021 Sep;100(9):101301. doi: 10.1016/j.psj.2021.101301. Epub 2021 Jun 4. Poult Sci. 2021. PMID: 34273651 Free PMC article.
-
Long-term chemically protected sodium butyrate supplementation in broilers as an antibiotic alternative to dynamically modulate gut microbiota.Poult Sci. 2022 Dec;101(12):102221. doi: 10.1016/j.psj.2022.102221. Epub 2022 Oct 4. Poult Sci. 2022. PMID: 36334430 Free PMC article.
-
Short-term supplementation with uncoated and encapsulated Enterococcus faecium affected growth performance, gut microbiome and intestinal barrier integrity in broiler chickens.Poult Sci. 2024 Jul;103(7):103808. doi: 10.1016/j.psj.2024.103808. Epub 2024 Apr 26. Poult Sci. 2024. PMID: 38761463 Free PMC article.
-
A Meta-Analysis of the Effects of Dietary Yeast Mannan-Rich Fraction on Broiler Performance and the Implication for Greenhouse Gas Emissions from Chicken Production.Animals (Basel). 2024 May 28;14(11):1595. doi: 10.3390/ani14111595. Animals (Basel). 2024. PMID: 38891642 Free PMC article. Review.
-
Antioxidant Indexes and Immune Function of the Intestinal Flora of Compound Microecological Preparations.Oxid Med Cell Longev. 2022 Sep 30;2022:5498514. doi: 10.1155/2022/5498514. eCollection 2022. Oxid Med Cell Longev. 2022. Retraction in: Oxid Med Cell Longev. 2024 Jan 9;2024:9780381. doi: 10.1155/2024/9780381 PMID: 36238651 Free PMC article. Retracted. Review.
References
-
- Abdel-Latif, M. A., El-Far A. H., Elbestawy A. R., Ghanem R., Mousa S. A., and Abd El-Hamid H. S... 2017. Exogenous dietary lysozyme improves the growth performance and gut microbiota in broiler chickens targeting the antioxidant and non-specific immunity mRNA expression. PLoS One. 12:e0185153. doi:10.1371/journal.pone.0185153 - DOI - PMC - PubMed
-
- Bao, C. L., Liu S. Z., Shang Z. D., Liu Y. J., Wang J., Zhang W. X., Dong B., and Cao Y. H... 2020. Bacillus amyloliquefaciens TL106 protects mice against enterohemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function, and gut microbiota. J. Anim. Sci. 131:470–484. doi:10.1111/jam.14952. . - DOI - PubMed
-
- Baumgart, M., Dogan B., Rishniw M., Weitzman G., Bosworth B., Yantiss R., Orsi R. H., Wiedmann M., McDonough P., Kim S. G.,. et al.. 2007. Culture-independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn’s disease involving the ileum. J. Anim. Sci. 1:403–418. doi:10.1038/ismej.2007.52 - DOI - PubMed
-
- Bui, T. P. N., Mannerås-Holm L., Puschmann R., Wu H., Troise A. D., Nijsse B., Boeren S., Bäckhed F., Fiedler D., and deVos W. M... 2021. Conversion of dietary inositol into propionate and acetate by commensal Anaerostipes associates with host health. Nat. Commun. 12:4798. doi:10.1038/s41467-021-25081-w - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical